Aspirin resistance increases risk of death

DALLAS, March 26 For the first time, researchers have shown that people who are aspirin resistant have a higher risk of dying from heart disease than people who are not aspirin resistant, according to a study in todays rapid access issue of Circulation: Journal of the American Heart Association.

Aspirin blocks the formation of thromboxane A2, a chemical in the body that makes platelets sticky and promotes blood clotting. However, lead author John W. Eikelboom, MBBS, says it appears that aspirin does not effectively block thromboxane synthesis in some people. This makes them resistant to the protective effects of the drug.

In the study, patients taking aspirin who had a high level of thromboxane in their urine had a 3.5 times higher risk of cardiovascular death than patients who had the lowest level says Eikelboom, a clinical lecturer at the University of Western Australia, Royal Perth Hospital, Perth, Australia.

The American Heart Association recommends aspirin for all patients with artery disease and a second antiplatelet medicine for those with uncontrolled chest pain called unstable angina.

Eikelboom cautions that the findings dont suggest a need to limit aspirin use. For most patients, aspirin therapy can reduce the risk for cardiovascular events by 25 percent. Our results suggest that some patients may need more protection than aspirin alone can offer, he says.

Researchers used data collected by the Heart Outcomes Prevention Evaluation (HOPE) study. This was a randomized, placebo-controlled study that compared the efficacy of a blood pressure drug, ramipril, and vitamin E to prevent heart attacks or stroke in patients with heart disease. The current study is based on data collected on 5,529 patients enrolled at 129 Canadian study sites. All patients provided baseline urine specimens, which were analyzed for levels of a chemical called 11-dehydro thromboxane B2, a byproduct of thromboxane A2.

High levels of 11-dehy

Contact: Carole Bullock
American Heart Association

Page: 1 2

Related medicine news :

1. Aspirins potential ability to prevent colon polyps may not apply equally to all
2. Aspirin underused to reduce heart disease risk in diabetic women and young adults
3. Long Island Breast Cancer Study data: Aspirin helps protect some women against breast cancer
4. Aspirin use associated with reduced risk of breast cancer
5. Aspirin use may be associated with increased risk of pancreatic cancer
6. Aspirin is most cost effective way to prevent heart disease
7. Aspirin withdrawal may pose risk to coronary patients
8. Aspirin does not reduce effectiveness of ACE inhibitors
9. Aspirin may help prevent pancreatic cancer
10. Aspirins target, the COX-2 enzyme, linked to cancer of the uterus
11. Aspirin within two days of ischemic stroke reduces deaths

Post Your Comments:

(Date:5/23/2019)... ... May 23, 2019 , ... Summit ... the opening of its seventeenth treatment center, Bel Aire Recovery Center. Located in ... in the Sunflower State. The facility is located in the natural landscape of ...
(Date:5/23/2019)... ... May 23, 2019 , ... More than 25 million Americans ... or changes the passage of light into the eye. Prevent Blindness , the ... Month to educate the public on risk factors, symptoms and treatment options. , ...
(Date:5/23/2019)... (PRWEB) , ... May 23, 2019 , ... Carrie Romandine, ... 50 Most Powerful Women in Healthcare IT . , This is the ... country. The awards were given to women in the following professional categories:, ...
(Date:5/23/2019)... , ... May 23, 2019 , ... ... industry, today announced that Lean Human Capital has selected the winners of its ... Lean Human Capital by HealthcareSource has recognized excellence in healthcare recruitment. All winners ...
(Date:5/23/2019)... ... May 23, 2019 , ... Neurohacker Collective , ... with Emerson Ecologics. Qualia Mind, Qualia Focus, and Qualia Mind Caffeine Free are ... Emerson’s extensive nearly 40 year history of providing the broadest selection of wellness ...
Breaking Medicine News(10 mins):
(Date:5/23/2019)... ... May 23, 2019 , ... Over 68% of healthcare organizations have adopted a ... (the custom research division of Worldwide Business Research , the global leader in ... currently offer clinical aromatherapy report positive (44%) or highly positive (22%) patient responses. , ...
(Date:5/23/2019)... ... May 23, 2019 , ... Greenlight Guru, ... is bringing their 2019 True Quality Roadshow, a seven-city, countrywide gathering of medical ... Block Event Center & Venue. , The True Quality Roadshow will ...
(Date:5/23/2019)... ... 2019 , ... NeoTract, a wholly owned subsidiary of Teleflex ... announced that Elizabeth Mobley, MD, Urology Austin in Austin, TX, has been designated ... has achieved a high level of training and experience with the UroLift® System ...
Breaking Medicine Technology:
Cached News: